A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound, is now available in the United States.

The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Patents for Victoza and Saxenda have now expried. So other drug companies are working to develop “generic” versions.

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

Moreover, Victoza 3 mg led to a significant reduction (-1.3%) in blood glucose (HbA1c) from baseline compared to placebo (-0.4%). A significantly higher percentage of patients (72.3%) achieved the ...

Also, Victoza is given daily, while Ozempic is given only once weekly. Additionally, Victoza can be used in children as young as 10, while Ozempic is only approved for adults 18 and older.

The percentage of people without insurance coverage for Victoza went up by 92% since 2024, corresponding to 31 million people. Meanwhile, the percentage change for Saxenda was 47%, or 31 million ...

Novo Nordisk's (NVO) Victoza receives FDA nod for its label expansion to include cardiovascular events in adult patients with type II diabetes. Shares up.

Novo Nordisk's Victoza, a popular diabetes medication, has shown mixed results in a mid-stage trial targeting Alzheimer's disease. While the drug failed to meet its primary endpoint of improving ...

She weighed 209 pounds at the time and was prediabetic. The doctor told her she had to get down to 165 pounds and was prescribed Victoza to manage her prediabetic condition. She never imagined it ...